Bedirhan Kilerci
Overview
Explore the profile of Bedirhan Kilerci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morgan R, Clamp A, White D, Price M, Burghel G, Ryder W, et al.
Clin Cancer Res
. 2023 Feb;
29(14):2602-2611.
PMID: 36799931
Purpose: A single maintenance course of a PARP inhibitor (PARPi) improves progression-free survival (PFS) in germline BRCA1/2-mutant high-grade serous ovarian cancer (gBRCAm-HGSOC). The feasibility of a second maintenance course of...
2.
Mohan S, Foy V, Ayub M, Leong H, Schofield P, Sahoo S, et al.
J Thorac Oncol
. 2019 Oct;
15(2):216-230.
PMID: 31629061
Introduction: SCLC accounts for approximately 250,000 deaths worldwide each year. Acquisition of adequate tumor biopsy samples is challenging, and liquid biopsies present an alternative option for patient stratification and response...
3.
Mohan S, Ayub M, Rothwell D, Gulati S, Kilerci B, Hollebecque A, et al.
Sci Rep
. 2019 Aug;
9(1):11610.
PMID: 31406261
Serial biopsy of pancreatic ductal adenocarcinoma (PDAC), to chart tumour evolution presents a significant challenge. We examined the utility of circulating free DNA (cfDNA) as a minimally invasive approach across...
4.
Rothwell D, Ayub M, Cook N, Thistlethwaite F, Carter L, Dean E, et al.
Nat Med
. 2019 Apr;
25(5):738-743.
PMID: 31011204
Next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) supports blood-based genomic profiling but is not yet routinely implemented in the setting of a phase I trials clinic. TARGET is a...